JOSLIN MEDALISTS RANDOM C-PEPTIDE Modified from Keenan..King et al Diabetes on line Aug 10, 2010 Residual Insulin Production and Pancreatic B Cell Turnover.

Slides:



Advertisements
Similar presentations
Long-term Effects of The Hyperglycemic Intrauterine Environment Diabetes, Obesity and Fetal Programming Pennington Biomedical Research Center April 22,
Advertisements

Pathophysiology of Type 1 Diabetes
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
1 Diagnosis of Type 1 Diabetes. 2 Classifying Diabetes IAA, autoantibodies to insulin; GADA, glutamic acid decarboxylase; IA-2A, the tyrosine phosphatase.
Diabetes Nhung H. Nguyen. Definition: “A metabolic disease in which the body’s inability to produce any or enough insulin causes elevated levels of glucose.
10 th Biennial Conference Management of Diabetes in Youth Keystone, July 12-16, 2008 Barbara Davis Center for Childhood Diabetes.
Non-Invasive Cardiac Monitoring in Type 1 Diabetes Marian Rewers, MD, PhD Professor & Clinical Director Barbara Davis Center for Childhood Diabetes University.
Keystone Diabetes in Youth Snowmass: Jan 23, 2008 Clinical diabetes and Endocrinology Book on Immunology Diabetes With teaching.
Assignment for April 1, 2008 In class We will watch a Bill Moyers’ documentary, Children in America’s Schools.
Clinical Endocrinology 2009 Increased height and weight at 12 months only in siblings developing DM.
MSc in Diabetes A population approach Ross Lawrenson Postgraduate Medical School University of Surrey Epidemiology of Type 1 Diabetes UniS.
 Research Topic Type 1 Diabetes by Sonia Donaires.
The Burden of Diabetes 1. Prevalence of Diabetes and Prediabetes in the United States 2 1. CDC. National diabetes fact sheet, 2008.
Burden of Type 1 Diabetes
The Burden of Diabetes.
ACCORD - Action to Control Cardiovascular Risk in Diabetes ADVANCE - Action in Diabetes to Prevent Vascular Disease VADT - Veterans Administration Diabetes.
1 The Burden of Type 1 Diabetes. 2 Incidence and Prevalence of Type 1 Diabetes Type 1 diabetes mellitus (T1DM) is the major type of diabetes in youth.
MSc in Diabetes A population approach Ross Lawrenson Postgraduate Medical School University of Surrey Impaired glucose tolerance and undiagnosed diabetes.
Diagnosis of Type 1 Diabetes
Caring for Children With Special Medical Conditions
Genes, Environment- Lifestyle, and Common Diseases Chapter 5.
Fetal Origins of Disease Hypothesis Grace M. Egeland, Ph.D. University of Bergen.
Obesity and Type 2 Diabetes in children and adolescents Eva Tsalikian M.D. Stead family Department of Pediatrics Pediatric Endocrinology and Diabetes April.
Docs Adopt© Childhood Obesity Prevention
Note No cow’s milk or cow’s milk products (including but not limited to cheese and yoghurt) under the age of one year -casein (a protein in cow’s milk)
Health Disparities of Minority Women and Diabetes Kathleen M. Rayman, Ph.D., RN Appalachian Center for Translational Research in Disparities Faculty Development.
Obesity among Hispanics - a brief demographic account Rodolfo Valdez, Ph.D., M. Sc. Division of Diabetes Translation Centers for Disease Control and Prevention.
Diabetes. Diabetes Prevalence in U.S., (CDC)
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
The Autoimmune insulin-dependent Diabetes mellitus: Major immunologic Features: 1- HLA-DR3 and DR4 haplotype expression on the beta cells of the islets.
Pathophysiology of Type 1 Diabetes 1. Type 1 Diabetes Mellitus Characterized by absolute insulin deficiency Pathophysiology and etiology –Result of pancreatic.
The genetic bases BY Casey Jaroche
IDC 1.1 Global and National Burden of Diabetes Diabetes Mellitus: classification New (WHO) Screening and Diagnostic Criteria –Diabetes, Impaired Glucose.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
1 Genes, Environment- Lifestyle, and Common Diseases Chapter 5.
ACANTHOSIS NIGRICANS IN SCHOOL AGE CHILDREN IN FORT WORTH TEXAS Ximena Urrutia-Rojas, DrPH John A. Menchaca, MD Naveed Ahmad, MD Manuel Bayona, MD, PhD.
Focus Area 24 Respiratory Diseases Progress Review June 29, 2004.
Diabetes. Diabetes mellitus, or simply diabetes, is a group of metabolic diseases in which a person has high blood sugar, either because the body does.
Autoimmune Insulin Dependent Diabetes Mellitus (Type 1 Diabetes Mellitus) :
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Burden of Type 1 Diabetes
Genetic Testing and the Prevention of Type 1 Diabetes Janice S. Dorman, Ph.D. September 4, 2001.
How Can We Cure Diabetes? Clayton E. Mathews, Ph. D. Department of Pathology Diabetes Center of Excellence University of Florida College of Medicine.
Categories of disease Genetic (born with – even if disease doesn’t develop till later in life) Infectious – Virus and bacterial Environmental / Self-inflicted.
Healthy People 2010 Focus Area 5 Diabetes Progress Review December 18, 2002.
August 20, 2003 Focus Area 14: Immunization and Infectious Diseases Progress Review.
Both of our parents immigrated from Kerala, India to America for better lives and a better future for their family. They have been living here for 15 years.
©2012 Cengage Learning. All Rights Reserved. Chapter 4 Common Chronic Medical Conditions Affecting Children’s Health.
 Research Findings and Need for Nutrition Policies for Challenges to Healthy Development  Risks include: Food insecurity Malnutrition and overnutrition.
TYPE 1 DIABETES UPDATE Colorado Association for School-Based Health Care G. Todd Alonso, MD May 6, 2016.
DIPP-aineiston hallinnan ja avaamisen haasteet DIPP – Finnish Type 1 Diabetes Prediction and Prevention Study Jorma Toppari University of Turku Tämä teos.
The Burden of Diabetes.
The Burden of Diabetes.
Pathophysiology of Type 1 Diabetes
Burden of Type 1 Diabetes
Diabetes Mellitus.
Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-matched Controls: A Population-Based Study in Metropolitan Atlanta F.
Diabetes Mellitus.
Diagnosis of Type 1 Diabetes
Macrovascular Complications Microvascular Complications
RJ Jacobs AS Meyerhoff Capitol Outcomes Research, Inc.
Role of Research Question
Genetic Testing and the Prevention of Type 1 Diabetes
Dr Stephanie Jones, Dr Amal Khanolkar, Dr Krystyna Matyka,
Diabetes.
Diabetes mellitus II - III First and second type of diabetes mellitus
Jennifer McVean, MD September 23, 2010
The Burden of Diabetes.
Burden of Type 1 Diabetes
Presentation transcript:

JOSLIN MEDALISTS RANDOM C-PEPTIDE Modified from Keenan..King et al Diabetes on line Aug 10, 2010 Residual Insulin Production and Pancreatic B Cell Turnover after 50 Years of Diabetes: Joslin Medalist ?Subject M9 C-pep=1.66 Type B Pathology nPOD ? Subject M8 C-pep=.16 Lobular Type A Pathology nPOD BDC Controls Rnadom C-Peptide =

PSEUDOATROPHIC/ TYPE A TYPE B-DM2-CONTORLS Gianani et al Dimorphic histopathology of long-standing childhood-onset diabetes Diabetologia 2010

PATTERN A PSEUDOATROPHIC ISLETS (ABSENT BETA CELLS) IN LOBULAR DISTRIBUTION

Clinical Endocrinology 2009 Increased height and weight at 12 months only in siblings developing DM

Type 1 Diabetes n The incidence of childhood type 1 diabetes varies with geographic location, age, sex, ethnicity and time period. n Increase in Type 1 incidence worldwide n SEARCH study “indicates” rise incidence vs. CO registry

Diabetes in Youth in the U.S. 170,000 patients younger than 20 y 1,500,000 patients with type 1 diabetes all ages Number of new patients annually has tripled in the past 20 years REWERS

Percent Type 1 versus Type 2 Diabetes by Age onset (0-9 versus 10-19) Dabelea, SEARCH JAMA 2007; 297:

Extra 2.9% Dead by Age 30 Laing et al Diabetic Medicine 16, , 1999

Laing et al Diabetic Medicine 16, , 1999 Of Diabetes Deaths 18% male hypo and 6% female not counting epilepsy and dead unattended

T1D incidence is rising 3-5% per year Due to environmental cause(s) Incidence /100,000/ yr in children aged 0-14 REWERS

Accelerating Incidence Type 1 Diabetes Finland: Lancet 371:1778 Harjutsalo; Sjoberg; Tuomilehto May 2008

Finland Incidence Type 1 DM/100K Diabetes Care: 22:

Finland Type 1 Diabetes Incidence (32 years) Relative Percent Increase Diabetes Care: 22:

Incidence per 100,000 per year Swiss Males Schoenle et al. Diabetologia: 2,001, 44:286

Enterovirus Infection Finnish DIPP Study Hyoty et al Diabetes 49:1314, 2000

Incidence Type 1 Diabetes per 100,000 per year Children <=14 Karvonnen et al., Diabetes Care, 23:1516, 2000

Worldwide Incidence of Type 1 Diabetes in Children < 14 Years, by Sex Karvonen et al., Diabetes Care, 23, 2000

Relative Increase in Incidence of Type 1 Diabetes in Children < 14 Years Change globally: 2.5 % per year ( ) Onkamo et al, Diabetologia 42, 1999

Incidence of Type 1 Diabetes in Romania, by County Age < 14 years Serban, et al, JPEM,

Risk by the age of 20 years

High Risk Groups High Risk Groups n Scandinavia - < 5% IDDM cases worldwide n Relatives - only about 10% of the cases n Children - < 40% of the cases n HLA-DR3/4 - about 30-40% of childhood cases

Promoters - genes? - virus? - diet ? Natural history of type 1 diabetes Natural history of type 1 diabetes Genetic susceptibility Initiators - virus? - diet? No autoimmunity Autoimmunity Remission Clinical diabetes

Genetic Susceptibility to T1 DM

Alleles and Haplotypes in T1 DM Families J. Noble, HBDI

HLA-Defined T1 DM Risk Groups DAISY, Denver Population, n=21,713

Congenital Rubella Syndrome n 30% diabetic usually early IDDM, some NIDDM n incubation period 5-20 yrs n ICA, IAA in up to 80% of those with diabetes n HLA-DR3 or 3/4 in those with diabetes n other autoimmune diseases (thyroid, AD) n molecular mimicry with a 52kD autoantigen n animal model - Syrian hamsters n no diabetes after postnatal infection or MMR vacc.

Causes of congenital rubella syndrome Host embryo/fetus HLA-DR3/4 Agent rubella virus Environment unimmunized mother Vector maternal blood

Enteroviruses - recent studies

Richardson, Willcox, Bone, Foulis and Morgan Prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human Type 1 diabetes Diabetologia(2009) 52:

Enterovirus Infection Finnish DIPP Study Hyoty et al Diabetes 49:1314, 2000

Interferon-alpha Therapy and Type 1 Diabetes Mellitus Fabris et al, Aliment Pharmacol Ther 2003: 18: n Review: 31 cases type 1 diabetes n Hepatitis C- 3% islet ab+, increase to 7% n 9/18 cases type 1 diabetes had anti-islet antibodies (ab+) prior to interferon Rx n 23/30 (77%) ab+ at diagnosis n 8 cases transient insulin dependence Consider Islet Ab Testing Interferon Rx

Early childhood diet and T1 DM ?

TRIGR 3-yr Follow-up Results Seroconversion to 1+ Autoantibody p=0.043 n=173

Exposure to cow’s milk and islet autoimmunity Norris et al., JAMA 1996 Norris, et al., JAMA 2003 N=1,181 Similar results: Hummel 2000 Couper 1999 Odds Ratio Relative Risk Rewers

Similar findings: Hummel et al. BABY-DIAB, Diabetes Care 1996 No association between immunizations and islet autoimmunity Graves et al., DAISY, Diabetes Care 1999 No difference in % vaccinated before 9 months of age No difference in the median age at the first dose of DTP, Hib, Polio, HepB No difference in the % receiving HepB at birth No difference in the median number of doses of Polio, DTP Rewers

n Do environmental agents cause type 1 diabetes? YES n Can can autoimmune diseases, including T1 DM be prevented by modification of environment ? YES n Is this the “easiest” way to prevention? PROBABLY

Where are We Today? Average A1c by Age, *11-18 yrs; ^the original 14 centers, unchanged compared to 1998 Age Intensive RxHvidoere N=1,295^ Sweden (80% of the nation) Los Angeles N=1664 BDC Denver N=3910 DCCT N=195 EDIC N=175 < *^8.48.4*8.6 > REWERS

T1D patients diagnosed in childhood live longer NishmuraR, et al. Diabetes Care 2001 Duration of diabetes (yrs) Duration of diabetes (yrs) REWERS

Incidence of microvascular complications is declining Hovind P, et al. Diabetes Care Diabetic nephropathyProliferative diabetic retinopathy REWERS

Poor control of hypertension and dyslipidemia in young adult patients with T1D Hypertension Dyslipidemia Maahs D, Diabetes Care 2005 Wadwa P, Diabetes Care 2005 REWERS

Type 2 Diabetes n Apparent increase in 2 diabetes in youth in several populations – especially American Indians, Hispanics and African Americans n Lack of population based studies n Undiagnosed cases n Cases with severe acute symptoms misclassified n Cases reported mainly by pediatric endocrinologists

Reports of Type 2 Diabetes in Youth n Population-based o Pima o Navajo o Cree & Ojibway o NHANES III n School-based o Japan n Clinic-based or Case series o IHS » AI o Cincinnati OH »NHW and AA o Little Rock AK oAA, NHW o Charleston SC »AA o San Diego CA »NHW, H, A, AA o Ventura CA »H o San Antonio TX »H, NHW A – Asian Americans AI – American Indians AA – African Americans H - Hispanics NHW – non-Hispanic whites

Characteristics of Adolescents at Diagnosis with Type 2 Diabetes n Most are minority children (AA, AI, H) n More girls than boys (F:M ratio = ) n Mean age: 13 years n > 80% have a history of diabetes in a first degree relative n Obese (Average BMI > 30) n > 60% have acanthosis nigricans

The Changing Face of Diabetes in Youth

Type 2 by Ethnicity, the Barbara Davis Center Experience Dabelea

Incidence of Type 2 Diabetes in Japanese Children, Kitagawa et. al., Clinical Ped, 37, 1998 Age (years)

Prevalence of Type 2(?) Diabetes in Population-Based Studies - per 1000 [95%CI] - n New Mexico ( ) Navajo Indians years 14.1 [0-33.5] n Arizona ( ) Pima Indians years 22.3 [ ] n Manitoba ( ) Cree & Ojibway Indians 4-19 years 11.1[ ] n NHANES III ( ) NHW, AA, H years 4.1 [0-8.6] Fagot-Campagna, et al., J Pediatr,136, 2000

Prevalence of Type 2 DM in Pima Indian Youth Dabelea et al., Diabetologia, 41, 1998

Recent observations n Possible change in the phenotype of “typical” Type 1 diabetes in youth – to more obese, with less severe clinical onset n Reports of “atypical” diabetes with mixed phenotypes in youth

Distribution of Body Mass Index by Type of Diabetes Age years at diagnosis Barbara Davis Center for Childhood Diabetes Denver, CO Dabelea

Incidence of Diabetes in U.S. Children, by ethnicity* NHW (1) H (1) AA (2) AA (3) Pima (4) NHW, H: 0-17 years AA Type 1: 0-14 years AA Type 2: years Pima: years * 1. Kostraba, Epidemiology, 3, Libman, Diabetes Care, 16, Pinhas-Hamiel, J Pediatr, 128, Unpublished data Is it still so?

Types of Childhood Diabetes in Different Ethnic Groups: Is This True? Whites Other ethnicities American Indians Dabelea

Instructions for obtaining article and slideset: Early infant feeding and risk of developing type 1 diabetes- associated autoantibodies. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. JAMA 2003 Oct 1;290(13): Go to Sign in or register. Select the Diabetes Forum from the drop down list. Click on the Selected Articles link. In the chronological list, scroll to Oct. 6 th, 2003 articles. Select Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. JAMA 2003 Oct 1;290(13):1721-8: The abstract will appear. Choose from many options, including Download Article & Download Slides.